Clinical Trial Update: Effect of Sarpogrelate on Platelet Aggregation in Patients With Cerebral Infarction: Dose-responsive Clinical Pharmacology Study [Phase 3]

View source ↗

Summary

A completed Phase 3 study evaluating the effect of Sarpogrelate on platelet aggregation in patients with cerebral infarction, with dose-related pharmacological …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Infarction

Drugs mentioned

• Sarpogrelate (sarpogrelate)

Snippet

Sponsor: Tanabe Pharma Corporation | Conditions: Cerebral Infarction | Phase 3 | Status: COMPLETED